Adcendo
DenmarkEntry
2026
Hold
New
Status
Active
Who owns Adcendo?
Adcendo is a Danish Biotech company, currently owned by Eifo since 2026 and 4 other investors.
Hand-verified · updated 2026-05-13
Open JSON · CC-BY
Key takeaways
- ·Co-held by Novo Holdings, Ysios Capital Partners, Eifo, Bpifrance Investissement and Jeito Capital since 2021.
- ·5 distinct PE sponsors across ownership cycles.
Ownership history
5 ownership periods · co-invest detected
Active
Co-held by Novo Holdings, Ysios Capital Partners, Eifo, Bpifrance Investissement and Jeito Capital since 2021.
Co-invest · 2 holders · 2021 · present
Novo HoldingsActive
2021 · present(5yr) · Novo Holdings Seed Investments · 1999 · VC
Ysios Capital PartnersActive
2021 · present(5yr) · Ysios BioFund III · 2020 · Life Sciences VC
EifoActive
2026 · present(<1yr) · EIFO (direct equity) · 1992 · VC
Bpifrance InvestissementActive
2026 · present(<1yr) · Large Venture · 2013 · Growth
Jeito CapitalActive
2026 · present(<1yr) · Jeito II · 2026 · VC
More from Jeito II
Other portfolio companies in the same fund.
US
France
Belgium
NetherlandsMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Adcendo?
Adcendo is currently owned by Eifo, Bpifrance Investissement and 3 others, through Jeito II, since 2026.
When did Eifo and 4 others acquire Adcendo?
Eifo and 4 others acquired Adcendo in 2026.
Who has owned Adcendo over time?
Adcendo has been through 5 private-equity ownership periods: Novo Holdings · via Novo Holdings Seed Investments · since 2021; Ysios Capital Partners · via Ysios BioFund III · since 2021; Eifo · via EIFO (direct equity) · since 2026; Bpifrance Investissement · via Large Venture · since 2026; Jeito Capital · via Jeito II · since 2026.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue